Selenium in Intensive Care (SIC): Results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock*
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Sepsis is associated with an increase in reactive oxygen species and low endogenous antioxidative capacity. We postulated that high-dose supplementation of sodium-selenite would improve the outcome of patients with severe sepsis and septic shock. DESIGN: Prospective randomized, placebo-controlled, multiple-center trial. SETTING: Eleven intensive care units in Germany. PATIENTS: Patients were 249 patients with severe systemic inflammatory response syndrome, sepsis, and septic shock and an Acute Physiology and Chronic Health Evaluation (APACHE) III score >70. INTERVENTIONS: Patients received 1000 microg of sodium-selenite as a 30-min bolus injection, followed by 14 daily continuous infusions of 1000 microg intravenously, or placebo. MEASUREMENTS AND MAIN RESULTS: The primary end point was 28-day mortality; secondary end points were survival time and clinical course of APACHE III and logistic organ dysfunction system scores. In addition, selenium levels in serum, whole blood, and urine as well as serum glutathione-peroxidase-3 activity were measured. From 249 patients included, 11 patients had to be excluded. The intention-to-treat analysis of the remaining 238 patients revealed a mortality rate of 50.0% in the placebo group and 39.7% in the selenium-treated group (p = .109; odds ratio, 0.66; confidence interval, 0.39-1.1). A further 49 patients had to be excluded before the final analysis because of severe violations of the study protocol. In the remaining 92 patients of the study group, the 28-day mortality rate was significantly reduced to 42.4% compared with 56.7% in 97 patients of the placebo group (p = .049, odds ratio, 0.56; confidence interval, 0.32-1.00). In predefined subgroup analyses, the mortality rate was significantly reduced in patients with septic shock with disseminated intravascular coagulation (n = 82, p = .018) as well as in the most critically ill patients with an APACHE III score > or =102 (>75% quartile, n = 54, p = .040) or in patients with more than three organ dysfunctions (n = 83, p = .039). Whole blood selenium concentrations and glutathione peroxidase-3 activity were within the upper normal range during selenium treatment, whereas they remained significantly low in the placebo group. There were no side effects observed due to high-dose sodium-selenite treatment. CONCLUSIONS: The adjuvant treatment of patients with high-dose sodium-selenite reduces mortality rate in patients with severe sepsis or septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The importance of selenium to human health
Rayman, M. P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02490-9 · Cited by 4,163
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Le Gall, J.-R. (1996) · JAMA · doi:10.1001/jama.1996.03540100046027 · Cited by 735
Burk, R. F., & Hill, K. E. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132120 · Cited by 577
Gall, J. R. L. (1996) · JAMA · doi:10.1001/jama.276.10.802 · Cited by 543
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
Trends in selenium biochemistry
Birringer, M., Pilawa, S., & Flohé, L. (2002) · Nat. Prod. Rep. · doi:10.1039/b205802m · Cited by 440
Heyland, D. K., Dhaliwal, R., Suchner, U., & Berger, M. M. (2005) · Intensive Care Medicine · doi:10.1007/s00134-004-2522-z · Cited by 438
Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients
Forceville, X., Vitoux, D., Gauzit, R., Combes, A., Lahilaire, P., & Chappuis, P. (1998) · Critical Care Medicine · doi:10.1097/00003246-199809000-00021 · Cited by 338
Immune cells: free radicals and antioxidants in sepsis
Victor, V. M., Rocha, M., & De la Fuente, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.020 · Cited by 310
Selenium deficiency increases the pathology of an influenza virus infection
Beck, M. A., Nelson, H. K., Shi, Q., Van Dael, P., Schiffrin, E. J., Blum, S., Barclay, D., & Levander, O. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0721fje · Cited by 290
Selenoprotein Metabolism and Function: Evidence for More than One Function for Selenoprotein P
Burk, R. F., Hill, K. E., & Motley, A. K. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.5.1517s · Cited by 287
Angstwurm, M. W. A., Schottdorf, J., Schopohl, J., & Gaertner, R. (1999) · Critical Care Medicine · doi:10.1097/00003246-199909000-00017 · Cited by 254
Self-citationBerger, M. M., Spertini, F., Shenkin, A., Wardle, C., Wiesner, L., Schindler, C., & Chiolero, R. L. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.2.365 · Cited by 223
Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock
Macarthur, H., Westfall, T. C., Riley, D. P., Misko, T. P., & Salvemini, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9753 · Cited by 205
Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors
Cowley, H. C., Bacon, P. J., Goode, H. F., Webster, N. R., Jones, J. G., & Menon, D. K. (1996) · Critical Care Medicine · doi:10.1097/00003246-199607000-00019 · Cited by 205
Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic
Schomburg, L., Schweizer, U., & K�hrle, J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4114-z · Cited by 202
Prabhu, K. S., Zamamiri-Davis, F. A., STEWART, J. B., Thompson, J. T., Sordillo, L. M., & Reddy, C. C. (2002) · Biochemical Journal · doi:10.1042/bj20020256 · Cited by 172
Alterations of serum selenium concentrations in the acute phase of pathological conditions
Maehira, F., Luyo, G. A., Miyagi, I., Oshiro, M., Yamane, N., Kuba, M., & Nakazato, Y. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00744-6 · Cited by 164
Therapeutic Intervention and Targets for Sepsis
Rice, T. W., & Bernard, G. R. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104356 · Cited by 158
Selenium supplementation to prevent short-term morbidity in preterm neonates
Darlow, B. A., & Austin, N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003312 · Cited by 149
Redox events in interleukin-1 signaling
Brigelius‐Flohé, R., Banning, A., Kny, M., & Böl, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.12.008 · Cited by 128
Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients
Lyons, J., Rauh-Pfeiffer, A., Ming-Yu, Y., Lu, X.-M., Zurakowski, D., Curley, M., Collier, S., Duggan, C., Nurko, S., Thompson, J., et al. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00036 · Cited by 127
Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase
MILLER, S., WALKER, S. W., ARTHUR, J. R., NICOL, F., PICKARD, K., LEWIN, M. H., HOWIE, A. F., & BECKETT, G. J. (2001) · Clinical Science · doi:10.1042/cs1000543 · Cited by 126
The facts and controversies about selenium.
Dodig, S., & Čepelak, I. (2004) · Acta Pharmaceutica · Cited by 117
Mode of Action of Endotoxin: Role of Free Radicals and Antioxidants
Bhattacharyya, J., Biswas, S., & Datta, A. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456098 · Cited by 109
Evidence-Based Medicine in the ICU
Vincent, J. (2004) · CHEST Journal · doi:10.1378/chest.126.2.592 · Cited by 102
Darlow, B. A., Winterbourn, C. C., Inder, T. E., Graham, P. J., Harding, J. E., Weston, P. J., Austin, N. C., Elder, D. E., Mogridge, N., Buss, I. H., et al. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)90010-6 · Cited by 96
Redox regulation of neutrophil apoptosis and the systemic inflammatory response syndrome
Melley, D. D., Evans, T. W., & Quinlan, G. J. (2005) · Clinical Science · doi:10.1042/cs20040228 · Cited by 84
Selenium supplementation for critically ill adults
Avenell, A., Noble, D. W., Barr, J., & Engelhardt, T. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003703.pub2 · Cited by 68
Nève, J. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200211000-00008 · Cited by 68
Hunter, E. A. L., & Grimble, R. F. (1997) · Clinical Science · doi:10.1042/cs0920297 · Cited by 66
The facts and controversies about selenium.
Dodig, S., & Čepelak, I. (2004) · PubMed · Cited by 64
Shimohashi, N., Nakamuta, M., Uchimura, K., Sugimoto, R., Iwamoto, H., Enjoji, M., & Nawata, H. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20000915)78:4<595::aid-jcb9>3.0.co;2-b · Cited by 54
[Selenium administration in patients with sepsis syndrome. A prospective randomized study].
Zimmermann, T., Albrecht, S., Kühne, H., Vogelsang, U., Grützmann, R., & Kopprasch, S. (1997) · Medizinische Klinik · doi:10.1007/bf03041947 · Cited by 52
Self-citationSando, K., Hoki, M., Nezu, R., Takagi, Y., & Okada, A. (1992) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719201600154 · Cited by 35
Tiran, B., Tiran, A., Rossipal, E., & Lorenz, O. (1993) · PubMed · Cited by 32
Selenium: An Acute-Phase Reactant?
Sattar, N. A., Eatock, F., Fell, G. S., & O’Reilly, D. S. J. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400419 · Cited by 31
[Septic shock and selenium administration].
Forceville, X., Aouizerate, P., & Guizard, M. (2001) · PubMed · Cited by 15
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
“5 (3-121) ICU 30 (1-560) Hosp 26 (4-407) Hosp SD, standard deviation; NR, not reported; ICU, intensive care unit; SICU, surgical ICU; Hosp, hospital; LOS, length of stay.”
ESPEN guidelines on parenteral nutrition: intensive care
Singer, P., Berger, M. M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., & Pichard, C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.024 · Cited by 1,907
McClave, S. A., Martindale, R. G., Vanek, V. W., McCarthy, M., Roberts, P., Taylor, B., Ochoa, J. B., Napolitano, L., Cresci, G., the A.S.P.E.N. Board of Directors, et al. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109335234 · Cited by 1,873
Metadata
- Authors
- Angstwurm, M. W. A., Engelmann, L., Zimmermann, T., Lehmann, C., Spes, C. H., Abel, P., Strauß, R., Meier-Hellmann, A., Insel, R., Radke, J., Schüttler, J., & Gärtner, R.
- Venue
- Critical Care Medicine
- Published
- 2007-01
- Volume
- 35
- Issue
- 1
- Pages
- 118-126
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2156514608
- Cited by
- 509
- References
- 45
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.